Literature DB >> 11228368

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

M M Morris-Downes1, K V Phenix, J Smyth, B J Sheahan, S Lileqvist, D A Mooney, P Liljeström, D Todd, G J Atkins.   

Abstract

This study has examined the persistence, distribution and pathological changes following intramuscular administration of Semliki Forest virus (SFV) vaccine vectors in mice and chickens. Administration of recombinant SFV RNA particles showed persistence at the injection site of mice up to 7 days, transient detection in secondary lymphoid organs and no dissemination to distal sites. In contrast, administration of a layered SFV DNA/RNA vector and a conventional standard naked DNA vector resulted in long-term persistence at the injection site, plasmid DNA being detected at 8 months post-inoculation in mice. Plasmid DNA was found distributed throughout the body, and tissues distal from the site of injection were positive up to 3 months. A similar pattern was observed in chickens. Mild pathological changes were observed at the injection site only, and plasmid DNA or recombinant RNA was not detected in mouse foetuses. These findings indicate that SFV-based vectors have the potential to be developed as safe vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11228368     DOI: 10.1016/s0264-410x(00)00428-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Angel A Oñate; Gabriel Donoso; Gustavo Moraga-Cid; Hugo Folch; Sandra Céspedes; Edilia Andrews
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Human immunodeficiency virus type 1 env trimer immunization of macaques and impact of priming with viral vector or stabilized core protein.

Authors:  Andreas Mörner; Iyadh Douagi; Mattias N E Forsell; Christopher Sundling; Pia Dosenovic; Sijy O'Dell; Barna Dey; Peter D Kwong; Gerald Voss; Rigmor Thorstensson; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

4.  Intradermal electroporation of naked replicon RNA elicits strong immune responses.

Authors:  Daniel X Johansson; Karl Ljungberg; Maria Kakoulidou; Peter Liljeström
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

5.  Evaluation of the persistence and gene expression of an anti-Chlamydophila psittaci DNA vaccine in turkey muscle.

Authors:  Karolien Loots; Bart Vleugels; Ellen Ons; Daisy Vanrompay; Bruno Maria Goddeeris
Journal:  BMC Vet Res       Date:  2006-06-09       Impact factor: 2.741

Review 6.  Alphavirus-based vaccines.

Authors:  Kenneth Lundstrom
Journal:  Viruses       Date:  2014-06-16       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.